Schedule 13G ownership disclosure

Vera Therapeutics Inc

Class A common stock, $0.001 par value per share · CUSIP: 92337R101

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Kynam Capital Management, LP

    Shares: 3,426,887 · Class: 5.37%

  • Kynam Capital Management GP, LLC

    Shares: 3,426,887 · Class: 5.37%

  • Yue Tang

    Shares: 3,426,887 · Class: 5.37%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-005108
Form type
SCHEDULE 13G
Filer
Kynam Capital Management, LP
CIK
CIK 1907884
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub